VR for Joint Attention Support in ASD

Withdrawn before enrolling · Phase 2

Conditions studied: Autism Spectrum Disorder

In brief

The overall objective of this study is to determine the effectiveness of the Floreo VR Joint Attention Module in improving social communication skills in children with ASD. An additional objective is ongoing investigation of the tolerability of the product and the extent of potential adverse effects of Floreo VR, if any.

Key facts

Study ID

NCT04016701

Run by

Floreo, Inc.

People needed

0

Starts

2018-07-20

Expected to finish

2019-07-16

Last updated by the study team

2019-07-17

Who can join

Age: 7 and older, up to 17. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Documented ASD diagnosis, between 7 and 17 years of age

You may not qualify if…

• History of seizures, migraines, vertigo, psychosis

Where it is running

• Children's SPOT — Columbia, Maryland, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.